Dr David Kim is the Founder at CyanoCapture - a company that began at the University of Oxford, harnessing GM synechococcus to make carbon removal an energy-efficient and low-cost technology for the world.
Helen Philippou is a Professor of Translational Medicine at the University of Leeds. Recently she co-founded and is CEO of ClotProtect Therapeutics a spin-out company developing a small molecule therapeutic to stem bleeding in patients. Previously she co-founded LUNAC Therapeutics which was shortlisted for 4 "Start-up" awards and won 3 of these in 2020 and 2021. LUNAC was featured in J.P. Morgan's first-ever Top 200 Female-Powered Businesses report, where LUNAC was rated 55 out of 6,085 UK high-growth companies in 2021. . Prof Philippou also featured as a Mover and Shaker in 2021 BioBusiness Report, BioBeat.